Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain.

Pharmacological Reviews
Muhammad Saad YousufTheodore J Price

Abstract

Dysfunction in regulation of mRNA translation is an increasingly recognized characteristic of many diseases and disorders, including cancer, diabetes, autoimmunity, neurodegeneration, and chronic pain. Approximately 50 million adults in the United States experience chronic pain. This economic burden is greater than annual costs associated with heart disease, cancer, and diabetes combined. Treatment options for chronic pain are inadequately efficacious and riddled with adverse side effects. There is thus an urgent unmet need for novel approaches to treating chronic pain. Sensitization of neurons along the nociceptive pathway causes chronic pain states driving symptoms that include spontaneous pain and mechanical and thermal hypersensitivity. More than a decade of preclinical research demonstrates that translational mechanisms regulate the changes in gene expression that are required for ongoing sensitization of nociceptive sensory neurons. This review will describe how key translation regulation signaling pathways, including the integrated stress response, mammalian target of rapamycin, AMP-activated protein kinase (AMPK), and mitogen-activated protein kinase-interacting kinases, impact the translation of different subsets of mR...Continue Reading

References

Jan 1, 1991·Journal of Neuroscience Research·A GiudittaB B Kaplan
Apr 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·A GiudittaM Brzin
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·H KawasomeN Terada
Jun 5, 1998·The Journal of Biological Chemistry·F PoulinN Sonenberg
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·S W ThompsonS B McMahon
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·R J MannionC J Woolf
Nov 21, 2000·Current Opinion in Neurobiology·K C MartinE R Kandel
Jul 23, 2002·The Journal of Biological Chemistry·Wendy L ZollWilliam C Merrick
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Nov 9, 2002·European Journal of Biochemistry·Gert C Scheper, Christopher G Proud
Jul 19, 2003·Genes & Development·Ken InokiKun-Liang Guan
Oct 15, 2003·Neuron·Oswald Steward, Erin M Schuman
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Josephine LaiMichael S Gold
Feb 19, 2004·The Journal of Biological Chemistry·Susan W Y ChengPeter R Shepherd
Mar 11, 2004·The Journal of Biological Chemistry·Jana NarasimhanRonald C Wek
Jul 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Krishna M Vattem, Ronald C Wek
Oct 7, 2004·Nature Cell Biology·Estela JacintoMichael N Hall
Oct 12, 2004·Annual Review of Cell and Developmental Biology·Michael Piper, Christine Holt

❮ Previous
Next ❯

Citations

Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francis GiraudPascale Moreau
Sep 18, 2021·Journal of Medicinal Chemistry·Weijun XuKassoum Nacro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Cephalalgia : an International Journal of Headache
T S Jensen
Best Practice & Research. Clinical Anaesthesiology
Steen Petersen-Felix, Lars Arendt-Nielsen
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
Lars Arendt-Nielsen, Hiroyuki Sumikura
© 2021 Meta ULC. All rights reserved